Vividion Therapeutics
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
5820 Nancy Ridge Dr, San Diego, Californ...Phone Number
(858) 345-4690Website
www.vividion.comRevenue
$34.1 MillionIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
3
1
1
1
2
About Vividion Therapeutics
Vividion is a next-generation biotechnology company focused on expanding the therapeutic potential of small molecules. They are applying pioneering synthetic chemistry and chemoproteomic platforms to reveal druggable opportunities across the entire proteome, much of it previously considered undruggable. Their goal is to create life-changing therapeutics for diseases and pathways not adequately addressed by existing treatments.Explore more
Vividion Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vividion Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Vividion Therapeutics
Check out if Vividion Therapeutics is spiking on competitors!
Earning: See what the market has to say on Vividion Therapeutics recently announced quarterly report
Product Launch: Get notified when Vividion Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Vividion Therapeutics had a recent Job posting/layoffs
Vividion Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Vividion Therapeutics has new funding data
Check if Vividion Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Vividion Therapeutics
Compare insights from companies similar to Vividion Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vividion Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Vividion Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Vividion Therapeutics.
Vividion Therapeutics financials insights
Gather financial insights about Vividion Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Private Equity
$3.5M
2017
Private Equity
$20.2M
Series A
$50M
2019
Series B
$82M
2021
Series C
$135M
Vividion Therapeutics Tech Stack
A closer look at the technologies used by Vividion Therapeutics
See more technologies
Most Recent Scoops
Open Position
Open Position
Project
, according to a mid-level source in diversity & inclusion, began leveraging AI-driven content creation / generation within the last six to twelve months.
Employee Relations, Artificial Intelligence, Company Culture & Policy, Diversity & Inclusion
Pain Point
Project
, according to a mid-level source in diversity & inclusion, is planning to remediate challenges related to employee experience. Vividion Therapeutics is planning to increase funding and update workflow. The organization is currently evaluating various vendors.
Pain Point, Spending/Investment, Financial Planning, Funding, Employee Engagement, Employee Relations, Company Culture & Policy, Diversity & Inclusion, Finance
Pain Point
Project
Pain Point, Analytics & Insights, Employee Relations, Company Culture & Policy, Diversity & Inclusion, HR Operations
Vividion Therapeutics News & Media
Vividion Therapeutics and Bayer Further Strengthen Oncology Development Pipeline with Clinical-Stage WRN Inhibitor
SAN DIEGO & BERLIN, Germany--(BUSINESS WIRE)--Vividion Therapeutics, Inc. (Vividion), a clinical-stage biopharmaceutical company, and a wholly owned and independently operated subsidiary of Bayer AG, today announced it has secured exclusive worldwide rights to develop and commercialize the clinical-stage Werner helicase (WRN) covalent inhibitor VVD-214 (RO7589831), strengthening and complementing its innovative oncology development pipeline. VVD-214 was discovered and developed under an exclusiVividion Therapeutics Announces Promotion of Jean Bemis to Chief Operating Officer
SAN DIEGO--(BUSINESS WIRE)--Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally undruggable targets and develop small molecule precision therapeutics for devastating cancers and immune disorders, today announced the promotion of Jean Bemis to Chief Operating Officer. Ms. Bemis is an accomplished biotech leader with vast experience across various innovative organizations, spanning from early discoveryVividion Therapeutics Acquires Tavros Therapeutics to Expand Functional Genomics Capabilities and Boost Drug Discovery Platform
SAN DIEGO & BERLIN & DURHAM, N.C.--(BUSINESS WIRE)--Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally undruggable targets and develop small molecule precision therapeutics for devastating cancers and immune disorders, today announced the acquisition of Tavros Therapeutics, Inc., a precision oncology platform company. Vividion is a wholly owned and independently operating subsidiary of Bayer AG. TheVividion Therapeutics Appoints Frank Poschen to Board of Directors
SAN DIEGO--(BUSINESS WIRE)--Vividion Therapeutics, Inc. (Vividion), a clinical stage biopharmaceutical company utilizing novel discovery technologies to unlock high-value, traditionally undruggable targets with precision therapeutics for devastating cancers and immune disorders, today announced the appointment of Frank Poschen, a pioneer in organizational change and dynamic talent leader, to its Board of Directors and as Chair of the Compensation Committee. Mr. Poschen, Senior Vice President of
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Vividion Therapeutics
Sign Up For FreeTo access detailed company insights
Vividion is a next-generation biotechnology company focused on expanding the therapeutic potential of small molecules. They are applying pioneering synthetic chemistry and chemoproteomic platforms to reveal druggable opportunities across the entire proteome, much of it previously considered undruggable. Their goal is to create life-changing therape... Read More
